We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Multimodal AI to Revolutionize Cardiovascular Disease Diagnosis and Treatment

By HospiMedica International staff writers
Posted on 20 Oct 2025

Cardiovascular diseases remain the leading cause of death worldwide, and while artificial intelligence (AI) has shown promise in their diagnosis and management, most existing systems rely on a single data type such as ECGs or cardiac imaging. More...

This limits diagnostic accuracy and prevents algorithms from reflecting the comprehensive reasoning process that physicians use in clinical practice. Now, a new multimodal AI approach aims to overcome this limitation by integrating diverse clinical data sources to deliver more accurate and personalized cardiovascular insights.

The study, led by West China Hospital of Sichuan University (Sichuan, China) and the University of Copenhagen (Copenhagen, Denmark), reviewed over 150 studies demonstrating the potential of multimodal AI in cardiovascular medicine. This next-generation approach fuses complementary data modalities—such as echocardiography, computed tomography, magnetic resonance imaging, and genomics—to enhance diagnostic precision. For example, a transformer-based neural network combining chest radiographs with clinical variables simultaneously identified 25 critical pathologies in intensive-care patients, achieving an average diagnostic accuracy (AUC) of 0.77.

The review, published in Precision Clinical Medicine, showed that multimodal AI can also reveal new biological insights. By integrating cardiac MRI with genome-wide association data, researchers identified novel genetic loci linked to aortic valve function. In addition to diagnosis, these models refined treatment decisions—predicting which heart-failure patients would respond to cardiac resynchronization therapy and identifying those unlikely to benefit from mitral-valve repair, thereby improving patient selection and treatment efficiency.

Emerging multimodal algorithms also enable continuous health monitoring by merging data from wearable devices, mobile applications, and electronic health records. These tools can detect early signs of deterioration, deliver automated health coaching, and reduce readmission rates. The authors estimate that adopting multimodal AI in clinical practice could reduce cardiovascular healthcare costs by 5%−10% over five years through improved efficiency and fewer complications.


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The light-activated Janus patches also hold great potential for various applications beyond neurosurgery (Kang, et al. Chemical Engineering Journal, 2026; DOI: 10.1016/j.cej.2025.171881)

Light-Activated Tissue Adhesive Patch Achieves Rapid and Watertight Neurosurgical Sealing

Durotomy, a tear in the dura mater during neurosurgery, can lead to cerebrospinal fluid leakage, delayed healing, headaches, and serious infections. Achieving a reliable, watertight dural closure is therefore... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: WHX in Dubai brings together over 235,000 professional visits and more than 4,300 global exhibitors from more than 180 countries

WHX in Dubai (formerly Arab Health) to bring together key UAE government entities during the groundbreaking 2026 edition

World Health Expo (WHX), formerly Arab Health, will bring together the UAE’s health authorities and leading healthcare sector bodies when the exhibition debuts at the Dubai Exhibition Centre (DEC) from... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.